Partial solubility parameters of piroxicam and niflumic acid

被引:46
|
作者
Bustamante, P [1 ]
Peña, MA
Barra, J
机构
[1] Univ Alcala de Henares, Fac Farm, Dept Farm & Tecnol Farmaceut, Madrid 28871, Spain
[2] Labs UPSA, F-92506 Rueil Malmaison, France
[3] Univ Geneva, Sch Pharm, CH-1211 Geneva, Switzerland
关键词
partial solubility parameters; piroxicam; niflumic acid; solubility;
D O I
10.1016/S0378-5173(98)00263-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The expanded Hansen method is tested with two anti-inflammatory drugs, piroxicam (preferentially Lewis base) and niflumic acid (preferentially Lewis acid). The original dependent variable, ln alpha(2)/U, where alpha is the activity coefficient and U is related to the molar volume of the solute and the volume fraction of the solvent, was compared with the direct use of the logarithm of the mole fraction solubility In X-2 in the three- and four parameter models. The activity coefficient of the drugs was calculated from the heat and temperature of fusion before and after equilibration of each solid phase with the pure solvents used. The dependent variables In X-2 and In alpha(2)/U provided similar partial solubility parameter values for piroxicam with the four parameter model. All the partial parameters of niflumic acid were significant statistically only with the variable ln X-2. This indicates that ln X-2 is the most suitable variable for the determination of partial solubility parameters. The dispersion solubility parameters are similar for both drugs, the largest differences being observed for the dipolar and hydrogen bonding parameters. The partial solubility parameters give insights into the interaction capability of the drugs and are consistent with their chemical structure. For niflumic acid, a better proton donor, delta(a) > delta(b) whereas for piroxicam, a preferentially Lewis base delta(b) > delta(a). This result is particularly interesting as it demonstrates for the first time the validity of the method for a mainly proton-acceptor compound. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:141 / 150
页数:10
相关论文
共 50 条
  • [1] Solubility of niflumic acid and celecoxib in supercritical carbon dioxide
    Tsai, Cheng-Chou
    Lin, Ho-Mu
    Lee, Ming-Jer
    JOURNAL OF SUPERCRITICAL FLUIDS, 2014, 95 : 17 - 23
  • [2] Solubility of niflumic acid and celecoxib in supercritical carbon dioxide
    Lee, Ming-Jer, 1600, Elsevier B.V., Netherlands (95):
  • [3] Solubility of niflumic acid and celecoxib in supercritical carbon dioxide
    Tsai, Cheng-Chou
    Lin, Ho-Mu
    Lee, Ming-Jer
    Journal of Supercritical Fluids, 2014, 95 : 17 - 23
  • [4] Redefining solubility parameters: the partial solvation parameters
    Panayiotou, Costas
    PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2012, 14 (11) : 3882 - 3908
  • [5] Biorelevant solubility of poorly soluble drugs: Rivaroxaban, furosemide, papaverine and niflumic acid
    Takacs-Novak, Krisztina
    Szoke, Vera
    Voelgyi, Gergely
    Horvath, Peter
    Ambrus, Rita
    Szabo-Revesz, Piroska
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2013, 83 : 279 - 285
  • [6] PARTIAL SOLUBILITY PARAMETERS FOR POLYDIMETHYLSILOXANE AND POLYETHYLMETHYLSILOXANE
    BANEY, RH
    VOIGT, CE
    MENTELE, JW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1976, 172 (SEP3): : 135 - 135
  • [7] COMPARISON OF THE ANALGESIC AND ANTIINFLAMMATORY EFFECTS OF TOPICAL NIFLUMIC ACID GEL VERSUS PIROXICAM GEL IN THE TREATMENT OF MUSCULOSKELETAL DISORDERS
    COMMANDRE, F
    ZAKARIAN, H
    CORRIOLROHOU, S
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1993, 53 (01): : 113 - 121
  • [8] NIFLUMIC ACID AND RHABDOMYOLYSIS
    DESVIGNES, V
    FIALIP, J
    PALCOUX, JB
    LAVARENNE, J
    THERAPIE, 1988, 43 (05): : 429 - 430
  • [9] Total and partial solubility parameters of supercritical methanol
    Marcus, Yizhak
    JOURNAL OF SUPERCRITICAL FLUIDS, 2016, 111 : 43 - 46
  • [10] Solubility Prediction of Drugs in Mixed Solvents Using Partial Solubility Parameters
    Jouyban, Abolghasem
    Shayanfar, Ali
    Panahi-Azar, Vahid
    Soleymani, Jafar
    Yousefi, Behrooz H.
    Acree, William E., Jr.
    York, Peter
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (10) : 4368 - 4382